The notch signaling pathway in esophageal adenocarcinoma

Zhiqiang Wang, J. Chen, Anthony J Capobianco

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The Notch signaling pathway plays a critical role in embryonic development, self-renewal of stem cells, and carcinogenesis. Aberrant Notch signaling has been linked to a wide variety of cancers, and can either suppress or promote tumors depending on the cell type and the context. Increasingly it is being realized that Notch signaling not only involves in the pathogenesis and development of esophageal adenocarcinoma (EAC), it also promotes the growth of EAC cells and also involved in the maintenance of EAC cancer stem cells. The efficacy of gamma-secretase inhibitor (GSI) in EAC treatment could have a major impact on easing the burden of this devastating disease. Therefore, it appears that inhibition of Notch sensitizes EAC cells to chemotherapeutic agents, which should lead to a better and more durable response to neoadjuvant chemotherapy (NAC). In this review, we bring to highlight how Notch plays a role in the development, tumorigenicity, and stemness of EAC cells, and how Notch signaling pathway could be a promising therapeutic target for the treatment of human EAC.

Original languageEnglish (US)
Pages (from-to)24-32
Number of pages9
JournalCellular and Molecular Biology
Volume61
Issue number6
DOIs
StatePublished - 2015

Fingerprint

Adenocarcinoma
Stem cells
Amyloid Precursor Protein Secretases
Chemotherapy
Tumors
Neoplastic Stem Cells
Esophageal Neoplasms
Embryonic Development
Neoplasms
Carcinogenesis
Therapeutics
Maintenance
Drug Therapy
Growth

Keywords

  • Barrett;s esophagus (BE)
  • Cancer stem cells (CSCs)
  • Esophageal adenocarcinoma (EAC)
  • Gamma-secretase inhibitor (GSI)
  • Notch signaling

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Cite this

The notch signaling pathway in esophageal adenocarcinoma. / Wang, Zhiqiang; Chen, J.; Capobianco, Anthony J.

In: Cellular and Molecular Biology, Vol. 61, No. 6, 2015, p. 24-32.

Research output: Contribution to journalArticle

@article{d680b47a243b4e3abf0a3a8008e54f26,
title = "The notch signaling pathway in esophageal adenocarcinoma",
abstract = "The Notch signaling pathway plays a critical role in embryonic development, self-renewal of stem cells, and carcinogenesis. Aberrant Notch signaling has been linked to a wide variety of cancers, and can either suppress or promote tumors depending on the cell type and the context. Increasingly it is being realized that Notch signaling not only involves in the pathogenesis and development of esophageal adenocarcinoma (EAC), it also promotes the growth of EAC cells and also involved in the maintenance of EAC cancer stem cells. The efficacy of gamma-secretase inhibitor (GSI) in EAC treatment could have a major impact on easing the burden of this devastating disease. Therefore, it appears that inhibition of Notch sensitizes EAC cells to chemotherapeutic agents, which should lead to a better and more durable response to neoadjuvant chemotherapy (NAC). In this review, we bring to highlight how Notch plays a role in the development, tumorigenicity, and stemness of EAC cells, and how Notch signaling pathway could be a promising therapeutic target for the treatment of human EAC.",
keywords = "Barrett;s esophagus (BE), Cancer stem cells (CSCs), Esophageal adenocarcinoma (EAC), Gamma-secretase inhibitor (GSI), Notch signaling",
author = "Zhiqiang Wang and J. Chen and Capobianco, {Anthony J}",
year = "2015",
doi = "10.14715/cmb/2015.61.6.5",
language = "English (US)",
volume = "61",
pages = "24--32",
journal = "Cellular and molecular biology (Noisy-le-Grand, France)",
issn = "0145-5680",
publisher = "Cellular and Molecular Biology Association",
number = "6",

}

TY - JOUR

T1 - The notch signaling pathway in esophageal adenocarcinoma

AU - Wang, Zhiqiang

AU - Chen, J.

AU - Capobianco, Anthony J

PY - 2015

Y1 - 2015

N2 - The Notch signaling pathway plays a critical role in embryonic development, self-renewal of stem cells, and carcinogenesis. Aberrant Notch signaling has been linked to a wide variety of cancers, and can either suppress or promote tumors depending on the cell type and the context. Increasingly it is being realized that Notch signaling not only involves in the pathogenesis and development of esophageal adenocarcinoma (EAC), it also promotes the growth of EAC cells and also involved in the maintenance of EAC cancer stem cells. The efficacy of gamma-secretase inhibitor (GSI) in EAC treatment could have a major impact on easing the burden of this devastating disease. Therefore, it appears that inhibition of Notch sensitizes EAC cells to chemotherapeutic agents, which should lead to a better and more durable response to neoadjuvant chemotherapy (NAC). In this review, we bring to highlight how Notch plays a role in the development, tumorigenicity, and stemness of EAC cells, and how Notch signaling pathway could be a promising therapeutic target for the treatment of human EAC.

AB - The Notch signaling pathway plays a critical role in embryonic development, self-renewal of stem cells, and carcinogenesis. Aberrant Notch signaling has been linked to a wide variety of cancers, and can either suppress or promote tumors depending on the cell type and the context. Increasingly it is being realized that Notch signaling not only involves in the pathogenesis and development of esophageal adenocarcinoma (EAC), it also promotes the growth of EAC cells and also involved in the maintenance of EAC cancer stem cells. The efficacy of gamma-secretase inhibitor (GSI) in EAC treatment could have a major impact on easing the burden of this devastating disease. Therefore, it appears that inhibition of Notch sensitizes EAC cells to chemotherapeutic agents, which should lead to a better and more durable response to neoadjuvant chemotherapy (NAC). In this review, we bring to highlight how Notch plays a role in the development, tumorigenicity, and stemness of EAC cells, and how Notch signaling pathway could be a promising therapeutic target for the treatment of human EAC.

KW - Barrett;s esophagus (BE)

KW - Cancer stem cells (CSCs)

KW - Esophageal adenocarcinoma (EAC)

KW - Gamma-secretase inhibitor (GSI)

KW - Notch signaling

UR - http://www.scopus.com/inward/record.url?scp=84962167853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962167853&partnerID=8YFLogxK

U2 - 10.14715/cmb/2015.61.6.5

DO - 10.14715/cmb/2015.61.6.5

M3 - Article

VL - 61

SP - 24

EP - 32

JO - Cellular and molecular biology (Noisy-le-Grand, France)

JF - Cellular and molecular biology (Noisy-le-Grand, France)

SN - 0145-5680

IS - 6

ER -